Volume 49, Issue 8 pp. 1060-1066
UNSOLICITED REVIEW

Should testing be initiated prior to amoxicillin challenge in children?

Elissa M. Abrams

Corresponding Author

Elissa M. Abrams

Section of Allergy and Clinical Immunology, Department of Pediatrics, University of Manitoba, Winnipeg, Manitoba, Canada

Correspondence

Elissa M. Abrams, FE125-685 William Avenue, Winnipeg, MB R3E 0Z2, Canada.

Email: [email protected]

Search for more papers by this author
Moshe Ben-Shoshan

Moshe Ben-Shoshan

Division of Allergy and Clinical Immunology, Department of Pediatrics, McGill University, Montreal, Quebec, Canada

Search for more papers by this author
First published: 29 May 2019
Citations: 14

Abstract

Amoxicillin is the most common antibiotic prescribed in children with increasing use over time. While up to 10% of children are labelled as amoxicillin allergic, most children can tolerate amoxicillin after allergy evaluation. It is well documented that the label of amoxicillin allergy in children is associated with adverse health outcomes such as antibiotic-resistant infections. However, it remains controversial how best to assess children for amoxicillin allergy. While in general it is recommended that skin testing be done prior to drug provocation test in the evaluation of amoxicillin allergy, there is increasing evidence that drug provocation testing could be done in lower risk children without skin testing prior. The goal of this article as a narrative review is to review the strengths and limitations of skin testing prior to drug provocation test in children who have a history of either immediate or non-immediate, reactions to amoxicillin.

CONFLICTS OF INTEREST

The authors declare no conflict of interest.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.